CRSP
NASDAQ
$46.99
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $86.21 (+83.46%)
Market Cap
$4.95B
Revenue 5Y CAGR
+30.10%
Free Cash Flow Yield
-8.10%
Beta (5Y)
1.44
Price Chart
Valuation
Market Cap$4.95B
Forward P/E23.36
P/S1211.19
P/B2.74
Profitability
Total Revenue (TTM)$4.10M
Gross Profit (TTM)-$479M
EBITDA-$627M
Operating Margin-8933%
EPS-$6.13
Financial Health
Debt-to-Equity32.3%
Free Cash Flow Yield-8.10%
Growth & Risk
EPS 5Y CAGR+2.10%
Revenue 5Y CAGR+30.10%
FCF 5Y CAGR+5.34%
Beta (5Y)1.44
Sharpe Ratio-0.01